Showing results (511-520 of 622) with videos related to

Sort By:
Pageof 63
Breast Cancer Research and Treatment|December 29, 2009
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancerMiguel Martín, Alvaro Rodríguez-Lescure, Amparo Ruiz, et al.
Eclinicalmedicine|July 3, 2025
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trialJosé Manuel Pérez-García, María Gion, Manuel Ruiz-Borrego, et al.
Gigascience|May 21, 2019
Rice Galaxy: an open resource for plant scienceVenice Juanillas, Alexis Dereeper, Nicolas Beaume, et al.
The Lancet. Oncology|May 8, 2025
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a studySantiago Escrivá-de-Romani, Juan M Cejalvo, Emilio Alba, et al.
Clinical & Developmental Immunology|July 18, 2013
New insights into the role of the immune microenvironment in breast carcinomaLuis de la Cruz-Merino, Antonio Barco-Sánchez, Fernando Henao Carrasco, et al.
Medicina (Kaunas, Lithuania)|January 25, 2025
Development of a Predictive Model of Occult Cancer After a Venous Thromboembolism Event Using Machine Learning: The CLOVER StudyAnabel Franco-Moreno, Elena Madroñal-Cerezo, Cristina Lucía de Ancos-Aracil, et al.
Pain Practice : the Official Journal of World Institute of Pain|December 10, 2013
A modified Delphi survey on the signs and symptoms of low back pain: indicators for an interventional management approachJosé Cid, José L De La Calle, Esther López, et al.
The Oncologist|April 4, 2025
Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studiesSara Lopez-Tarruella, Marina Pollán, Eva Carrasco, et al.
Primary Care Diabetes|July 11, 2020
Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohortManuel Ruiz-Quintero, Josep Redón, María Téllez-Plaza, et al.
Breast Cancer Research and Treatment|June 20, 2023
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registryMiguel Martín, Eva Carrasco, Álvaro Rodríguez-Lescure, et al.
Pageof 63